Archives for September 8, 2010

← 2010

Provexis commits to CV and immunity research

By Shane Starling

Biotech start-up Provexis says it will commence two clinical trials in 2011 – one in the area of cardiovascular inflammation, the other in treatment of “hospital superbug” c.difficile.

Euromonitor examines functional foods in continental Europe

By Lorraine Heller

Tighter spending, more stringent regulations and growing health concerns are all major factors impacting the European market for healthy foods. In the first article of a two-part series, NutraIngredients.com looks at the markets in France, Belgium,...

UK OK’s valerian sleep aids

By Shane Starling

Relaxation botanical, valerian, has won UK registrations under the European Union 2004 Traditional Herbal Medicinal Products Directive (THMPD), as the registration window moves closer to slamming shut.